Three Sensei directors to resign, new CEO & CFO conditional on stockholder approval

Sensei Biotherapeutics, Inc.

Christopher Gerry, Thomas Ricks, Kristian Humer resigning conditionally effective after June 10, 2026 annual meeting, contingent on stockholder approval of Conversion and Charter Amendment Proposals.
Conditional appointments of Stephen Hahn, Saira Ramasastry, Karen Vousden as new directors effective at same time.
If proposals approved, Anand Parikh (current COO) will become CEO; Brian Stephenson will become CFO. Gerry remains General Counsel, Craver remains SVP Finance.
Board adopted Severance and Change in Control Plan covering Parikh, Gerry, Craver with cash severance up to 18 months base salary and COBRA.
Conversion Proposal involves issuance of >20% of common upon Series B preferred conversion, resulting in change of control.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-158951
form_type: 8-K
ticker: SNSE
cik: 0001829802
company_name: Sensei Biotherapeutics, Inc.
filed_at: 2026-04-16T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.047329+00:00
generated_at: 2026-05-15T05:51:11.072261+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.9
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-158951
json_url: https://secwatch.observer/filing/0001193125-26-158951.json
markdown_url: https://secwatch.observer/filing/0001193125-26-158951.md
text_url: https://secwatch.observer/filing/0001193125-26-158951.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312526158951/0001193125-26-158951-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312526158951/d85136d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-158951

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.